1. Ezerskii V.A., Shishimorova M.S., Tevkin S.I., Trubitsina T.P., Koloskova E.M., Bezborodova O.A., et al. Integratsiya i tkanespetsifi cheskaya ekspressiya gena laktoferrina cheloveka v molochnoi zheleze transgennykh krolikov [Integration and tissue-specifi c expression of human lactoferrin gene in mammary gland of transgenic rabbits]. Problemy biologii produktivnykh zhivotnykh [Problems of biology of productive animals]. 2013;4:33–52. (In Russian).
2. Karkischenko V.N., Bolotskikh L.A., Kapanadze G.D., Karkischenko N.N., Koloskova E.M., Maksimenko S.V., et al. Sozdanie linij transgennykh zhivotnykh-modelej s genami cheloveka NAT1 i NAT2 [Creating lines of transgenic animal models with human genes NAT1 and NAT2]. Biomedicine. 2016;(1):74–85. (In Russian).
3. Karkischenko V.N., Ryabykh V.P., Bolotskikh L.A., Semenov Kh.Kh., Kapanadze G.D., Petrova N.V., et al. Fiziologo-embriologicheskie aspekty sozdaniya transgennyh myshej s integrirovannymi genami NAT1 i NAT2 cheloveka [Physiological and embryological aspects of creating transgenic mice with integrated human NAT1 and NAT2 genes]. Biomedicine. 2016;(1):52–66. (In Russian).
4. Karkischenko N.N., Ryabykh V.P., Koloskova E.M., Karkischenko V.N. Sozdanie gumanizirovannykh myshej dlya farmakotoksikologicheskikh issledovanij (uspekhi, neudachi i perspektivy) [Creation of humanized mice for pharmacotoxicological studies (successes, failures and prospects)]. Biomedicine. 2014;(3):4–22. (In Russian).
5. Makarenko I.E., Kalatanova A.V., Vanatiev G.V., Muzhikyan A.A., Shekunova E.V., Burenkov P.V., et al. Vybor optimal’nogo vida zhivotnykh dlya modelirovaniya eksperimental’nogo arterial’nogo tromboza [Selection of the optimal animal species for modeling experimental arterial thrombosis]. Mezhdunarodnyi vestnik veterinarii [International journal of veterinary medicine]. 2016;2:116–125. (In Russian).